SRZN

Surrozen, Inc. [SRZN] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

SRZN Stock Summary

Top 10 Correlated Stocks

SRZN


In the News

11:26 29 Nov 2023 SRZN

Here's Why Surrozen, Inc. (SRZN) Could be Great Choice for a Bottom Fisher

Surrozen, Inc. (SRZN) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

09:08 29 Nov 2023 SRZN

5 Top Stocks Likely to Come Up With Earnings Beat

These top-ranked stocks are likely to beat on the bottom line in their next releases. Tap Lamb Weston (LW), NeoGenomics (NEO), Surrozen (SRZN), KE Hodlings (BEKE) and Insperity (NSP).

09:54 29 Nov 2023 SRZN

New Strong Buy Stocks for April 12th

CELU, MGI, LRMR, EQRX and SRZN have been added to the Zacks Rank #1 (Strong Buy) List on April 12, 2023.

04:30 29 Nov 2023 SRZN

Surrozen To Report Fourth Quarter and Full Year 2022 Financial Results and Provide a Corporate Update on March 22, 2023

SOUTH SAN FRANCISCO, Calif., March 20, 2023 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), today announced that it will report fourth quarter and full year 2022 financial results and provide a corporate and pipeline progress report on Wednesday, March 22, 2023 after the close of the U.S. financial markets.   Company management will host a live audio webcast at 4:30 PM Eastern Time to discuss the corporate update and pipeline progress.

11:00 29 Nov 2023 SRZN

How to Diversify Your Penny Stock Investments

Use these tips for diversifying your investments in penny stocks The post How to Diversify Your Penny Stock Investments  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

12:07 29 Nov 2023 SRZN

Penny Stocks To Buy? 4 Cheap Stocks To Watch Right Now

High volume penny stocks to watch right now. The post Penny Stocks To Buy?

04:41 29 Nov 2023 SRZN

Surrozen to Present at the 41st Annual J.P. Morgan Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a company pioneering targeted therapeutics that selectively activate the Wnt pathway for tissue repair and regeneration, will present on January 12, 2023 at 7:30 a.m. Pacific time at the 41st Annual J.P. Morgan Healthcare Conference.

01:33 29 Nov 2023 SRZN

Surrozen, Inc. (SRZN) Upgraded to Buy: Here's What You Should Know

Surrozen, Inc. (SRZN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

08:00 29 Nov 2023 SRZN

Surrozen to Present Virtually at the 40th Annual J.P. Morgan Healthcare Conference

Surrozen to provide a business update including discussion of pipeline advancements Surrozen to provide a business update including discussion of pipeline advancements

08:00 29 Nov 2023 SRZN

Surrozen to Present at The Piper Sandler 33rd Annual Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Surrozen, Inc., (NASDAQ: SRZN), a biotechnology company discovering and developing drug candidates to selectively modulate the Wnt pathway, today announced that Craig Parker, Chief Executive Officer, will participate in a fireside chat at the Piper Sandler 33rd Annual Virtual Healthcare Conference at 10:00 a.m. ET on Monday, November 22. Interested parties may access the live webcast via the Investors section of the Surrozen website at www.surrozen.com. A replay of the webcast will be archived on the website.

SRZN Financial details

Company Rating
Neutral
Market Cap
14.06M
Income
-28.45M
Revenue
12.5M
Book val./share
1.49
Cash/share
1.42
Dividend
-
Dividend %
-
Employees
74
Optionable
No
Shortable
Yes
Earnings
08 Nov 2023
P/E
-0.48
Forward P/E
-0.39
PEG
0.09
P/S
1.1
P/B
0.3
P/C
0.32
P/FCF
-0.41
Quick Ratio
6.81
Current Ratio
7.25
Debt / Equity
0.09
LT Debt / Equity
0.03
-
-
EPS (TTM)
-0.97
EPS next Y
-1.16
EPS next Q
-0.28
EPS this Y
-62.44%
EPS next Y
19.59%
EPS next 5Y
-63.92%
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
9.68%
-
-
-
-
SMA20
2.33%
SMA50
-12%
SMA100
-29.03%
Inst Own
43.35%
Inst Trans
0.83%
ROA
-53%
ROE
-47%
ROC
-0.81%
Gross Margin
100%
Oper. Margin
-306%
Profit Margin
-228%
Payout
-
Shs Outstand
30.58M
Shs Float
18.5M
-
-
-
-
Target Price
-
52W Range
0.3-1.38
52W High
-
52W Low
-
RSI
53.45
Rel Volume
0.18
Avg Volume
90.06K
Volume
15.94K
Perf Week
9.68%
Perf Month
4.1%
Perf Quarter
-30.39%
Perf Half Y
-30.69%
-
-
-
-
Beta
-0.031
-
-
Volatility
0.02%, 0.04%
Prev Close
0.31%
Price
0.4497
Change
-2.87%

SRZN Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K
Revenue per share
000.36
Net income per share
-0.93-2.13-0.8
Operating cash flow per share
-0.83-1.98-1.27
Free cash flow per share
-0.86-2.03-1.29
Cash per share
1.44.132.18
Book value per share
1.354.442.19
Tangible book value per share
1.354.442.19
Share holders equity per share
1.354.442.19
Interest debt per share
0.270.320.11
Market cap
354.13M159M20.2M
Enterprise value
328.74M133.7M1.12M
P/E ratio
-10.85-3.03-0.73
Price to sales ratio
001.62
POCF ratio
-12.17-3.26-0.46
PFCF ratio
-11.81-3.17-0.45
P/B Ratio
7.491.450.27
PTB ratio
7.491.450.27
EV to sales
000.09
Enterprise value over EBITDA
-10.65-2.46-0.03
EV to operating cash flow
-11.3-2.74-0.03
EV to free cash flow
-10.97-2.67-0.02
Earnings yield
-0.09-0.33-1.37
Free cash flow yield
-0.08-0.31-2.22
Debt to equity
0.20.070.07
Debt to assets
0.150.060.06
Net debt to EBITDA
0.820.470.43
Current ratio
6.97.758.35
Interest coverage
0022.68
Income quality
0.890.891.23
Dividend Yield
000
Payout ratio
000
Sales general and administrative to revenue
001.59
Research and developement to revenue
002.96
Intangibles to total assets
000
Capex to operating cash flow
0.030.030.02
Capex to revenue
00-0.06
Capex to depreciation
-0.45-0.61-0.37
Stock based compensation to revenue
000.36
Graham number
5.3214.586.26
ROIC
-0.49-0.42-0.39
Return on tangible assets
-0.53-0.38-0.31
Graham Net
0.983.011.84
Working capital
42.95M91.62M71.57M
Tangible asset value
47.29M109.7M76M
Net current asset value
35.46M77.72M67.87M
Invested capital
0.20.070.07
Average receivables
00989K
Average payables
02.25M1.69M
Average inventory
000
Days sales outstanding
0057.76
Days payables outstanding
000
Days of inventory on hand
000
Receivables turnover
006.32
Payables turnover
000
Inventory turnover
000
ROE
-0.69-0.48-0.36
Capex per share
-0.02-0.05-0.02

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00.36000
Net income per share
-0.370.21-0.53-0.31-0.34
Operating cash flow per share
-0.4-0.01-0.47-0.29-0.33
Free cash flow per share
-0.41-0.01-0.48-0.29-0.33
Cash per share
2.242.182.061.781.42
Book value per share
2.222.192.11.831.49
Tangible book value per share
2.222.192.11.831.49
Share holders equity per share
2.222.192.11.831.49
Interest debt per share
0.160.340.160.150.13
Market cap
70.64M20.2M18.04M16.54M14.94M
Enterprise value
51.22M1.12M-4.69M-15.43M-15.07M
P/E ratio
-1.350.69-0.28-0.44-0.36
Price to sales ratio
01.62000
POCF ratio
-4.99-98.56-1.27-1.89-1.47
PFCF ratio
-4.94-57.24-1.25-1.87-1.47
P/B Ratio
0.910.270.290.30.33
PTB ratio
0.910.270.290.30.33
EV to sales
00.09000
Enterprise value over EBITDA
-3.76-0.510.391.581.96
EV to operating cash flow
-3.62-5.450.331.761.49
EV to free cash flow
-3.58-3.160.321.751.49
Earnings yield
-0.190.36-0.88-0.57-0.7
Free cash flow yield
-0.2-0.02-0.8-0.53-0.68
Debt to equity
0.080.070.080.080.09
Debt to assets
0.070.060.070.070.07
Net debt to EBITDA
1.438.81.873.273.9
Current ratio
9.568.358.618.937.25
Interest coverage
28.95-0.3549.4600
Income quality
1.060.260.990.930.97
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00.42000
Research and developement to revenue
00.75000
Intangibles to total assets
00000
Capex to operating cash flow
0.010.720.020.010
Capex to revenue
0-0.01000
Capex to depreciation
-0.31-0.31-0.65-0.170
Stock based compensation to revenue
00.12000
Graham number
4.323.225.023.593.39
ROIC
-0.150.23-0.22-0.15-0.23
Return on tangible assets
-0.140.08-0.21-0.15-0.19
Graham Net
1.91.841.741.531.2
Working capital
74.07M71.57M59.25M51.13M41.69M
Tangible asset value
77.49M76M63.04M55.06M45.53M
Net current asset value
68.78M67.87M55.87M48.64M39.92M
Invested capital
0.080.070.080.080.09
Average receivables
83.5K1.07M1.98M1.98M1.98M
Average payables
390K510K414.5K178.5K236.5K
Average inventory
1.69M1.69M000
Days sales outstanding
014.24000
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
06.32000
Payables turnover
00000
Inventory turnover
00000
ROE
-0.170.1-0.25-0.17-0.23
Capex per share
00-0.0100

SRZN Frequently Asked Questions

What is Surrozen, Inc. stock symbol ?

Surrozen, Inc. is a US stock , located in South san francisco of Ca and trading under the symbol SRZN

What is Surrozen, Inc. stock quote today ?

Surrozen, Inc. stock price is $0.4497 today.

Is Surrozen, Inc. stock public?

Yes, Surrozen, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated Stocks
Similar Market Cap